Literature DB >> 3777686

Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization.

R M Wachter, J M Luce, J Turner, P Volberding, P C Hopewell.   

Abstract

Eighty-two patients with the acquired immunodeficiency syndrome (AIDS) were admitted to the intensive care units (ICUs) at San Francisco General Hospital (SFGH) between March 1981 and December 1985. Of these patients, 69% died in the hospital, as did 87% of patients who required mechanical ventilation because of Pneumocystis carinii pneumonia and respiratory failure. Although the number of hospital admissions of patients with AIDS has increased steadily since the fourth quarter of 1982 (12 admissions) through the fourth quarter of 1985 (158 admissions), the number of admissions to the ICUs peaked at 17 in the second quarter of 1984 and decreased steadily, averaging 5 per quarter in 1985. This decrease was not explained by a reduction in the number of patients with P. carinii pneumonia or an improvement in their treatment. A survey of physicians at SFGH indicated that physicians are aware of the poor prognosis of patients with AIDS with P. carinii pneumonia and respiratory failure, believe that mechanical ventilation is infrequently indicated for this condition, and have become increasingly likely to discuss issues of resuscitation with their patients with AIDS. Therefore, possible explanations for this trend in ICU utilization include changing physician attitudes, in addition to more effective patient counseling and increased availability of hospital and community-based support services that provide alternatives to terminal intensive care.

Entities:  

Mesh:

Year:  1986        PMID: 3777686     DOI: 10.1164/arrd.1986.134.5.891

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  39 in total

Review 1.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  Purchasing care for people with HIV infection and AIDS.

Authors:  J Main; V Kitchen; S Lewis-Jones; V Moss
Journal:  Qual Health Care       Date:  1993-03

3.  Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe Pneumocystis carinii pneumonia.

Authors:  B Gachot; B Clair; M Wolff; B Régnier; F Vachon
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  HIV-associated tuberculosis: watch for it in your ICU.

Authors:  J F Murray
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 5.  AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome.

Authors:  D M Mitchell; M A Johnson
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

Review 6.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

7.  [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].

Authors:  O Braicks; K Anneken; D Reichelt; W R Schäbitz; R Dziewas; S Evers; I W Husstedt
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

8.  Trimethoprim-sulfamethoxazole desensitization in AIDS.

Authors:  G Papakonstantinou; H Füessl; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-04-15

9.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

Review 10.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.